EXOGENOUS PROGESTINS AND BREAST-CANCER

被引:46
作者
STANFORD, JL [1 ]
THOMAS, DB [1 ]
机构
[1] UNIV WASHINGTON, SCH PUBL HLTH & COMMUNITY MED, DEPT EPIDEMIOL, SEATTLE, WA 98195 USA
关键词
D O I
10.1093/oxfordjournals.epirev.a036120
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
[No abstract available]
引用
收藏
页码:98 / 107
页数:10
相关论文
共 53 条
[1]   ORAL-CONTRACEPTIVE USE INFLUENCES RESTING BREAST PROLIFERATION [J].
ANDERSON, TJ ;
BATTERSBY, S ;
KING, RJB ;
MCPHERSON, K ;
GOING, JJ .
HUMAN PATHOLOGY, 1989, 20 (12) :1139-1144
[2]   CELL TURNOVER IN THE RESTING HUMAN-BREAST - INFLUENCE OF PARITY, CONTRACEPTIVE PILL, AGE AND LATERALITY [J].
ANDERSON, TJ ;
FERGUSON, DJP ;
RAAB, GM .
BRITISH JOURNAL OF CANCER, 1982, 46 (03) :376-382
[3]   THE RISK OF BREAST-CANCER AFTER ESTROGEN AND ESTROGEN PROGESTIN REPLACEMENT [J].
BERGKVIST, L ;
ADAMI, HO ;
PERSSON, I ;
HOOVER, R ;
SCHAIRER, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (05) :293-297
[4]   ESTROGEN REPLACEMENT THERAPY AND BREAST-CANCER RISK [J].
BRINTON, LA ;
SCHAIRER, C .
EPIDEMIOLOGIC REVIEWS, 1993, 15 (01) :66-79
[5]  
Cancer and Steroid Hormone Study Investigators, 1986, NEW ENGL J MED, V315, P405, DOI 10.1056/NEJM198608143150701
[6]  
CHILVERS C, 1989, LANCET, V1, P973
[7]   PROGESTIN REGULATION OF CELLULAR PROLIFERATION [J].
CLARKE, CL ;
SUTHERLAND, RL .
ENDOCRINE REVIEWS, 1990, 11 (02) :266-301
[8]   ORAL-CONTRACEPTIVES AND BREAST-CANCER - A FRENCH CASE-CONTROL STUDY [J].
CLAVEL, F ;
ANDRIEU, N ;
GAIRARD, B ;
BREMOND, A ;
PIANA, L ;
LANSAC, J ;
BREART, G ;
RUMEAUROUQUETTE, C ;
FLAMANT, R ;
RENAUD, R .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1991, 20 (01) :32-38
[9]   TYPE OF POSTMENOPAUSAL HORMONE USE AND RISK OF BREAST-CANCER - 12-YEAR FOLLOW-UP FROM THE NURSES HEALTH STUDY [J].
COLDITZ, GA ;
STAMPFER, MJ ;
WILLETT, WC ;
HUNTER, DJ ;
MANSON, JE ;
HENNEKENS, CH ;
ROSNER, BA ;
SPEIZER, FE .
CANCER CAUSES & CONTROL, 1992, 3 (05) :433-439
[10]   ORAL-CONTRACEPTIVES AND BREAST-CANCER RISK IN DENMARK [J].
EWERTZ, M .
EUROPEAN JOURNAL OF CANCER, 1992, 28A (6-7) :1176-1181